While DDR1 has been involved in the growth of specific CRC cell line (Hu et al, 2014), we found that its expression level and its inhibition by nilotinib does not significantly modulate the in vitro growth of the tested CRC cell lines in standard conditions (Appendix Fig S3). This evidence concerns the gene DDR1 and colorectal carcinoma.